Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: IMMUNOMODULATORS, . Treffer: 11

2019

Bronsky, J; de Ridder, L; Ruemmele, FM; Griffiths, A; Buderus, S; Hradsky, O; Hauer, AC Diagnostic and Therapeutic Approach in Paediatric Inflammatory Bowel Diseases: Results from a Clinical Practice Survey.
J Pediatr Gastroenterol Nutr. 2019; 68(5):676-683
Web of Science PubMed FullText FullText_MUG

 

Woltsche, N; El-Shabrawi-Caelen, L; Deinlein, T; Kupsa, R; Gschwandtner, M; Hofmann-Wellenhof, R; Zalaudek, I [Eruptive epidermoid cysts after imiquimod treatment of recurrent basal cell carcinoma : A case report].
Hautarzt. 2019; 70(5):363-366 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Wenzl, HH; Primas, C; Novacek, G; Teml, A; Öfferlbauer-Ernst, A; Högenauer, C; Vogelsang, H; Petritsch, W; Reinisch, W Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.
Dig Dis Sci. 2015; 60(5):1414-1423
Web of Science PubMed FullText FullText_MUG

 

2013

König, S; Browne, S; Doleschal, B; Schernthaner, M; Poteser, M; Mächler, H; Wittchow, E; Braune, M; Muik, M; Romanin, C; Groschner, K Inhibition of Orai1-mediated Ca(2+) entry is a key mechanism of the antiproliferative action of sirolimus in human arterial smooth muscle.
Am J Physiol Heart Circ Physiol. 2013; 305(11):H1646-H1657 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Löhr, M; Molcanyi, M; Poggenborg, J; Spuentrup, E; Runge, M; Röhn, G; Härtig, W; Hescheler, J; Hampl, JA Intracerebral administration of heat-inactivated Staphylococcus epidermidis enhances oncolysis and prolongs survival in a 9L orthotopic gliosarcoma model.
Cell Physiol Biochem. 2013; 31(4-5): 614-624. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2006

Stauber, RE; Stadlbauer, V Novel approaches for therapy of chronic hepatitis C.
J CLIN VIROL. 2006; 36(2): 87-94.
Web of Science PubMed FullText FullText_MUG

 

2003

Neuhaus, O; Archelos, JJ; Hartung, HP Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection.
Trends Pharmacol Sci. 2003; 24(3):131-138
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Neuhaus, O; Wiendl, H; Kieseier, BC; Archelos, JJ; Hartung, HP Cholesterol-reducing medications-a new therapeutic option for multiple sclerosis? Statins as immunomodulators
NERVENARZT. 2003; 74(8): 704-707.
Web of Science PubMed FullText FullText_MUG

 

2002

Neuhaus, O; Strasser-Fuchs, S; Fazekas, F; Kieseier, BC; Niederwieser, G; Hartung, HP; Archelos, JJ Statins as immunomodulators: comparison with interferon-beta 1b in MS.
Neurology. 2002; 59(7):990-997
Web of Science PubMed FullText FullText_MUG

 

1998

Eber, E; Uhlig, T; McMenamin, C; Sly, PD Leflunomide, a novel immunomodulating agent, prevents the development of allergic sensitization in an animal model of allergic asthma.
Clin Exp Allergy. 1998; 28(3):376-384
Web of Science PubMed

 

Uhlig, T; Cooper, D; Eber, E; McMenamin, C; Wildhaber, JH; Sly, PD Effects of long-term oral treatment with leflunomide on allergic sensitization, lymphocyte activation, and airway inflammation in a rat model of asthma.
Clin Exp Allergy. 1998; 28(6):758-764
Web of Science PubMed

 

© Med Uni Graz Impressum